MétaCan
Menu
Back to cohort
Record W4397049554 · doi:10.1016/j.jaip.2024.05.016

Exploring Definitions and Predictors of Response to Biologics for Severe Asthma

2024· article· en· W4397049554 on OpenAlexafffund
Ghislaine Scélo, Trung N. Tran, Tham Le, Malin Fagerås, Delbert R. Dorscheid, John Busby, Mona Al‐Ahmad, Riyad Al‐Lehebi, Alan Altraja, Aaron Beastall, Céline Bergeron, Leif Bjermer, Anne Sofie Bjerrum, Giorgio Walter Canonica, Victoria Carter, Jérémy Charriot, George Christoff, Borja G. Cosío, Eve Denton, João Fonseca, Peter G. Gibson, Celine Goh, Liam G. Heaney, Enrico Heffler, Mark Hew, Takashi Iwanaga, Rohit Katial, Mariko Siyue Koh, Piotr Kuna, Désirée Larenas‐Linnemann, Lauri Lehtimäki, Bassam Mahboub, Neil Martin, Hisako Matsumoto, Andrew Menzies‐Gow, Nikolaos G. Papadopoulos, Pujan Patel, Luis Pérez de Llano, Matthew Peters, Paul Pfeffer, Todor A. Popov, Celeste Porsbjerg, Chin Kook Rhee, Mohsen Sadatsafavi, Camille Taillé, Carlos A. Torres-Duque, Ming‐Ju Tsai, Charlotte Suppli Ulrik, John W. Upham, Anna von Bülow, Eileen Wang, Michael E. Wechsler, David Price

Bibliographic record

VenueThe Journal of Allergy and Clinical Immunology In Practice · 2024
Typearticle
Languageen
FieldMedicine
TopicAsthma and respiratory diseases
Canadian institutionsVancouver General HospitalVancouver Hospital and Health Sciences CentreUniversity of British Columbia
FundersUCB PharmaEfficacy and Mechanism Evaluation ProgrammeSanofi GenzymeGenentechSeqirusShionogiCanadian Institutes of Health ResearchKuwait Foundation for the Advancement of SciencesMichael Smith Health Research BCCelltrionPfizerIncyteOptimum Patient CareAstraZenecaAllergy TherapeuticsNovartis Pharmaceuticals UK LimitedAKL Research and DevelopmentCSL BehringBritish Columbia Lung AssociationCanadian Thoracic SocietyRegeneron PharmaceuticalsGrifolsCerecorSingapore General HospitalEuropean Respiratory SocietyAmerican Thoracic SocietyChiesi FarmaceuticiCovis PharmaNovartis PharmaGlenmark PharmaceuticalsDanoneGilead SciencesCelltrion HealthcareEli Lilly and CompanySanofiOrient EuropharmaGlaxoSmithKlineAmgenMedical Research CouncilTeva Pharmaceutical Industries
KeywordsMedicineAsthmaExacerbationCohortIntensive care medicineInternal medicine

Abstract

fetched live from OpenAlex

Background Biologic effectiveness is often assessed as ‘response', a term which eludes consistent definition. Identifying those most likely to respond in real-life has proven challenging. Objective To explore definitions of biologic responders in adults with severe asthma and investigate patient characteristics associated with biologic response. Methods This was a longitudinal cohort study using data from 21 countries, which shared data with the International Severe Asthma Registry. Changes in 4 asthma outcome domains were assessed in the 1-year period pre- and post-biologic-initiation in patients with predefined level of pre-biologic impairment. Responder cut-offs were: ≥50% reduction in exacerbation rate, ≥50% reduction in long-term oral corticosteroid [LTOCS] daily dose, ≥1 category improvement in asthma control, and ≥100mL improvement in FEV1. Responders were defined using single- and multiple-domains. The association between pre-biologic characteristics and post-biologic-initiation response were examined by multivariable analysis. Results 2,210 patients were included. Responder rate ranged from 80.7% (n=566/701) for exacerbation-response to 10.6% (n=9/85) for 4-domain-response. Many responders still exhibited significant impairment post-biologic-initiation: 46.7% (n=206/441) of asthma control-responders with uncontrolled asthma pre-biologic still had incompletely-controlled disease post-biologic-initiation. Predictors of response were outcome-dependent. Lung function-responders were more likely to have higher pre-biologic FeNO (OR:1.20 for every 25ppb increase), and shorter asthma duration (OR:0.81, for every 10-year increase in duration). Higher BEC and presence of T2-related comorbidities were positively associated with higher odds of meeting LTOCS-, control- and lung function-responder criteria. Conclusion Our findings underscore the multi-modal nature of ‘response', show that many responders experience residual symptoms post-biologic-initiation, and that predictors of response vary according to outcome assessed.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.014
metaresearch head score (Gemma)0.045
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.014
Threshold uncertainty score0.076

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0140.045
Meta-epidemiology (narrow)0.0010.000
Meta-epidemiology (broad)0.0010.002
Bibliometrics0.0030.002
Science and technology studies0.0010.001
Scholarly communication0.0020.002
Open science0.0010.002
Research integrity0.0010.003
Insufficient payload (model declined to judge)0.0010.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.127
GPT teacher head0.384
Teacher spread0.256 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations33
Published2024
Admission routes2
Has abstractno

Explore more

Same venueThe Journal of Allergy and Clinical Immunology In PracticeSame topicAsthma and respiratory diseasesFrench-language works237,207